Main > PHARMA. > Enzyme Inhibitors > Therapy > Crosslinked Enzyme Crystal

Product USA. V

PATENT ASSIGNEE'S COUNTRY USA
UPDATE 01.00
PATENT ASSIGNEE Vertex Pharma
PATENT CLAIMS Oral adm of crosslinked enzyme crystal having resistance to exogenous proteolysis, such that said crosslinked enzyme retains > 91% of its initial activity after incubation for 3 hours in presence of a concn of Pronase that causes soluble uncrosslinked form to lose > 94% of its initial activity under same conditions
PATENT PHOTOCOPY Available on request

Want more information ?
Interested in the hidden information ?
Click here and do your request.


back